We demonstrate multiple advantages of using QCCs in CML routine quantitative BCR-ABL1 monitoring e.g. as to decide when experiments should be rejected while at the same time avoiding false alarm situations. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.